Transcriptomic Analysis and Validation Reveal the Pathogenesis and a Novel Biomarker of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2022 Feb 13

PMID 35151329

Authors

Huijie Wang

Yonghong Zhong

Na Li

Min Yu

Lin Zhu

Lina Wang

Fei Chen

Yaping Xu

Jian Liu

Huaqiong Huang

Affiliations

Soon will be listed here.

Abstract

Background: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is the main factor that leads to the deterioration of the disease. Currently, the diagnosis of AECOPD mainly relies on clinical manifestations, good predictors or biomarkers are lacking. We aim to reveal specific biomarkers and potential pathogenesis of AECOPD and provide a research basis for the diagnosis and treatment.

Methods: Four patients with AECOPD, four patients with stable COPD, and five control subjects were enrolled for RNA sequencing and KEGG analysis. The mRNA level of target genes was verified by quantitative real-time PCR (qPCR) with an expanded sample size (30 patients with AECOPD, 27 patients with stable COPD, and 35 control subjects). ELISA and immunofluorescence were used to identify the target proteins. Furthermore, the expression and function of WNT/β-catenin signaling pathway were assessed in animal models of COPD.

Results: RNA sequencing showed that 54 genes were up-regulated and 111 genes were down-regulated in the AECOPD. Differentially expressed genes were mainly enriched in WNT signaling pathway, et al. QPCR revealed that multi-genes of the WNT/β-catenin signaling were significantly down-regulated in AECOPD (P < 0.05), and β-catenin protein was significantly decreased in plasma of AECOPD and stable COPD (P < 0.01), while phosphorylated β-catenin was significantly up-regulated in peripheral blood mononuclear cells of AECOPD (P < 0.05). Similarly, WNT ligands, WNT receptors, and downstream signaling molecules were down-regulated, with an increased phosphorylated β-catenin protein in animal models of COPD. Activation of WNT/β-catenin signaling pathway by lithium chloride reduced the expression of phosphorylated β-catenin and ameliorated the COPD-like airway inflammation in mice.

Conclusion: WNT/β-catenin signaling pathway is down-regulated in AECOPD patients and in animal models of COPD. Increased expression of phosphorylated β-catenin in the blood might be a potential biomarker of AECOPD. Activation of WNT/β-catenin pathway may also represent a therapeutic target for AECOPD.

Citing Articles

Gene Expression Profiles Reveal Distinct Mechanisms Driving Chronic Obstructive Pulmonary Disease Exacerbations.

Bello-Perez M, Garcia-Pachon E, Gonzalo-Jimenez N, Ruiz-Garcia M, Zamora-Molina L, Baeza-Martinez C Int J Mol Sci. 2025; 26(2.

PMID: 39859341 PMC: 11765561. DOI: 10.3390/ijms26020627.

Evidence construction of Jinshuibao capsules against stable chronic obstructive pulmonary disease: A systematic review and network pharmacology.

Yin Y, Wang Y, Liu Y, Wang F, Wang Z Heliyon. 2024; 10(14):e34572.

PMID: 39082031 PMC: 11284407. DOI: 10.1016/j.heliyon.2024.e34572.

Systematic analysis of various RNA transcripts and construction of biological regulatory networks at the post-transcriptional level for chronic obstructive pulmonary disease.

Li B, Zhang J, Dong H, Feng X, Yu L, Zhu J J Transl Med. 2023; 21(1):790.

PMID: 37936118 PMC: 10631086. DOI: 10.1186/s12967-023-04674-7.

References

Skronska-Wasek W, Mutze K, Baarsma H, Bracke K, Alsafadi H, Lehmann M . Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017; 196(2):172-185. DOI: 10.1164/rccm.201605-0904OC. View

Skronska-Wasek W, Gosens R, Konigshoff M, Baarsma H . WNT receptor signalling in lung physiology and pathology. Pharmacol Ther. 2018; 187:150-166. DOI: 10.1016/j.pharmthera.2018.02.009. View

Gordon M, Nusse R . Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006; 281(32):22429-33. DOI: 10.1074/jbc.R600015200. View

Hussain M, Xu C, Lu M, Wu X, Tang L, Wu X . Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(12):3226-3242. DOI: 10.1016/j.bbadis.2017.08.031. View

Sharma A, Yang W, Ochani M, Wang P . Mitigation of sepsis-induced inflammatory responses and organ injury through targeting Wnt/β-catenin signaling. Sci Rep. 2017; 7(1):9235. PMC: 5569053. DOI: 10.1038/s41598-017-08711-6. View

Uhl F, Vierkotten S, Wagner D, Burgstaller G, Costa R, Koch I . Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J. 2015; 46(4):1150-66. DOI: 10.1183/09031936.00183214. View

Suo T, Chen G, Huang Y, Zhao K, Wang T, Hu K . miRNA-1246 suppresses acute lung injury-induced inflammation and apoptosis via the NF-κB and Wnt/β-catenin signal pathways. Biomed Pharmacother. 2018; 108:783-791. DOI: 10.1016/j.biopha.2018.09.046. View

Kim S, Lee J, Huh J, Ro J, Oh Y, Lee S . Cigarette smoke induces Akt protein degradation by the ubiquitin-proteasome system. J Biol Chem. 2011; 286(37):31932-43. PMC: 3173210. DOI: 10.1074/jbc.M111.267633. View

Zuo Q, Wang Y, Yang D, Guo S, Li X, Dong J . Identification of hub genes and key pathways in the emphysema phenotype of COPD. Aging (Albany NY). 2021; 13(4):5120-5135. PMC: 7950259. DOI: 10.18632/aging.202432. View

10.

Cui W, Zhang Z, Zhang P, Qu J, Zheng C, Mo X . Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β-catenin and AMPK pathways. J Cell Mol Med. 2018; 22(7):3514-3525. PMC: 6010849. DOI: 10.1111/jcmm.13628. View

11.

Wang Z, Gerstein M, Snyder M . RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2008; 10(1):57-63. PMC: 2949280. DOI: 10.1038/nrg2484. View

12.

Cheng J, Yang J, Xue K, Zhao Y, Zhao C, Li S . Desmoglein 3 Silencing Inhibits Inflammation and Goblet Cell Mucin Secretion in a Mouse Model of Chronic Rhinosinusitis via Disruption of the Wnt/β-Catenin Signaling Pathway. Inflammation. 2019; 42(4):1370-1382. DOI: 10.1007/s10753-019-00998-z. View

13.

Wu M, Lai T, Jing D, Yang S, Wu Y, Li Z . Epithelium-derived IL17A Promotes Cigarette Smoke-induced Inflammation and Mucus Hyperproduction. Am J Respir Cell Mol Biol. 2021; 65(6):581-592. DOI: 10.1165/rcmb.2020-0424OC. View

14.

Vogelmeier C, Criner G, Martinez F, Anzueto A, Barnes P, Bourbeau J . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017; 195(5):557-582. DOI: 10.1164/rccm.201701-0218PP. View

15.

MacNee W, Allan R, Jones I, De Salvo M, Tan L . Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial. Thorax. 2013; 68(8):738-45. DOI: 10.1136/thoraxjnl-2012-202744. View

16.

Pirozzi F, Ren K, Murabito A, Ghigo A . PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy. Curr Med Chem. 2018; 26(16):2791-2800. DOI: 10.2174/0929867325666180320120054. View

17.

Liu Y, Zhou J, White K . RNA-seq differential expression studies: more sequence or more replication?. Bioinformatics. 2013; 30(3):301-4. PMC: 3904521. DOI: 10.1093/bioinformatics/btt688. View

18.

Huang H, Li N, Li D, Jing D, Liu Z, Xu X . Autophagy Promotes Cigarette Smoke-Initiated and Elastin-Driven Bronchitis-Like Airway Inflammation in Mice. Front Immunol. 2021; 12:594330. PMC: 8019710. DOI: 10.3389/fimmu.2021.594330. View

19.

Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A . Increased activation of p38 MAPK in COPD. Eur Respir J. 2007; 31(1):62-9. DOI: 10.1183/09031936.00036707. View

20.

Wang Z, Li R, Zhong R . Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway. Mol Med Rep. 2018; 18(3):3143-3152. PMC: 6102654. DOI: 10.3892/mmr.2018.9320. View